Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry (MORE)

This study has been completed.
Information provided by (Responsible Party):
Celgene Corporation Identifier:
First received: October 29, 2010
Last updated: March 23, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)